Eli Lilly and Company logo
Eli Lilly and Company LLY
€ 900.45 -1.17%

Quartalsbericht 2025-Q2
hinzugefügt 07.08.2025

report update icon

Eli Lilly and Company P/S 2011-2025 | LLY

P/S Jährlich Eli Lilly and Company

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
17.3 19.5 10.4 7.97 7.43 6.12 4.89 3.96 3.87 4.38 4.08 2.57 2.75 1.8

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
19.5 1.8 6.93

P/S anderer Aktien in der Pharmaeinzelhändler

Name P/S Preis % 24h Marktkapitalisierung Land
AC Immune SA AC Immune SA
ACIU
35 $ 2.8 2.19 % $ 229 M schweizSchweiz
ADiTx Therapeutics ADiTx Therapeutics
ADTX
0.442 $ 2.49 -11.39 % $ 32.8 K usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
Abeona Therapeutics Abeona Therapeutics
ABEO
42.7 $ 4.59 -4.08 % $ 98.1 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
0.654 $ 12.12 -1.58 % $ 3.74 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
25.8 - 2.71 % $ 14 M usaUSA
Armata Pharmaceuticals Armata Pharmaceuticals
ARMP
110 $ 5.37 -20.68 % $ 194 M usaUSA
argenx SE argenx SE
ARGX
311 $ 919.62 2.76 % $ 25 B niderlandNiderland
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
947 $ 203.0 -3.72 % $ 5 B danmarkDanmark
Achieve Life Sciences Achieve Life Sciences
ACHV
3.19 $ 4.64 -0.32 % $ 92 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
1.85 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 3.36 2.73 % $ 8.08 B australiaAustralia
Acasti Pharma Acasti Pharma
ACST
0.203 - 4.01 % $ 150 M canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
4.6 $ 54.27 -1.38 % $ 10.3 B usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
34 - -15.15 % $ 60.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Baudax Bio Baudax Bio
BXRX
0.614 - 0.59 % $ 63 K usaUSA
AbbVie AbbVie
ABBV
22.7 $ 224.99 -0.01 % $ 398 B usaUSA
Cara Therapeutics Cara Therapeutics
CARA
2.58 - -3.03 % $ 260 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
110 - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
0.0564 - - $ 3.74 B usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 96.22 -1.21 % $ 27.2 B germanyGermany
Codiak BioSciences Codiak BioSciences
CDAK
10.5 - -55.98 % $ 2.15 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
6.58 $ 18.75 -0.48 % $ 2.76 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
3.03 - - $ 789 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
2.37 $ 1.92 -7.01 % $ 4.87 M usaUSA
Biogen Biogen
BIIB
2 $ 179.76 1.11 % $ 26.2 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
39.4 $ 23.52 -2.22 % $ 1.94 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
29.8 $ 3.45 -0.72 % $ 1.02 B canadaCanada
Cabaletta Bio Cabaletta Bio
CABA
50.3 M $ 2.37 -2.67 % $ 2.77 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
12.3 - - $ 25.3 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
26.1 - -6.63 % $ 13.9 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
1.55 - -7.23 % $ 13 M usaUSA
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Chimerix Chimerix
CMRX
320 - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
41.3 - - $ 401 M usaUSA